Rivas-Gomez B, Almeda-Valdés P, Tussié-Luna MT, Aguilar-Salinas CA

Idioma: Ingles.
Referencias bibliográficas: 30
Paginas: 211-216
Archivo PDF: 81.01 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Garcia-Garcia G, Aviles-Gomez R, Luquin-Arellano VH, et al. Cardiovascular risk factors in the Mexican population. Ren Fail. 2006;28:677-87.

2. Villarreal-Molina MT, Aguilar-Salinas CA, Rodríguez-Cruz M, et al. The ATP-binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities. Diabetes. 2007;56:1881-7.

3. Villarreal-Molina MT, Flores-Dorantes MT, Arellano-Campos O, et al. Association of the ATP-binding cassette transporter A1 R230C variant with early-onset Type 2 diabetes in a Mexican population. Diabetes. 2008;57:509-13.

4. Rojas R, Aguilar-Salinas CA, Jiménez-Corona A, et al. Metabolic syndrome in Mexican adults: results from the national health and nutrition survey 2006. Salud Publica Mex. 2010;52 Suppl 1:S11-8.

5. SSA. Encuesta Nacional de Enfermedades Crónicas 1993. México, D.F: Secretaría de Salud; 1994.

6. Aguilar-Salinas CA, Olaiz G, Valles V, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res. 2001;42:1298-307.

7. Aguilar-Salinas CA, Gómez-Pérez FJ, Rull J, et al. Prevalence of dyslipidemias in the Mexican national health and nutrition survey 2006. Salud Publica Mex. 2010;52 Suppl 1:S44-53.

8. Villalpando S, Shamah-Levy T, Rojas R, Aguilar-Salinas CA. Trends for Type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006. Salud Publica Mex. 2010;52 Suppl 1:S72-9.

9. Aguilar-Salinas CA, Tusie-Luna T, Pajukanta P. Genetic and environmental determinants of the susceptibility of Amerindian derived populations for having hypertriglyceridemia. Metabolism. 2014;63:887-94.

10. Escobedo-de la Peña J, de Jesús-Pérez R, Schargrodsky H, Champagne B. Prevalencia de dislipidemias en la ciudad de México y su asociación con otros factores de riesgo cardiovascular. Resultados del estudio CARMELA. Gac Med Mex. 2014;150:128-36.

11. Vinueza R, Boissonnet CP, Acevedo M, et al. Dyslipidemia in seven Latin American cities: CARMELA study. Prev Med. 2010; 50:106-11.

12. Aguilar-Salinas C, Canizales-Quinteros S, Rojas-Martínez R, Mehta R, Villarreal-Molina M, Arellano-Campos O. Hypoalphalipoproteinemia in populations of native American ancestry: an opportunity to assess the interaction of genes and the environment. Curr Opin Lipidol. 2009;20:92-7.

13. Solís-Olivares CA, Muñoz-Cardona M. Prevalencia de factores de riesgo cardiovascular en pacientes evaluados por dolor torácico. Rev Mex Cardiol. 2007;18:109-18.

14. Bibiloni MD, Salas R, De la Garza YE, et al. Serum lipid profile, prevalence of dyslipidaemia, and associated risk factors among northern Mexican adolescents. J Pediatr Gastroenterol Nutr. 2016;63:544-9.

15. Dron JS, Hegele RA. Genetics of triglycerides and the risk of atherosclerosis. Curr Atheroscler Rep. 2017;19:31.

16. Ko A, Cantor RM, Weissglas-Volkov D, et al. Amerindian-specific regions under positive selection harbour new lipid variants in Latinos. Nat Commun. 2014;5:3983.

17. Suárez-Sánchez F, Klunder-Klunder M, Valladares-Salgado A, et al. APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children. Pediatr Obes. 2017;12 330-6.

18. Parra EJ, Mazurek A, Gignoux CR, et al. Admixture mapping in two mexican samples identifies significant associations of locus ancestry with triglyceride levels in the BUD13/ZNF259/APOA5 region and fine mapping points to rs964184 as the main driver of the association signal. PLoS One. 2017;12:e0172880.

19. Aguilar-Salinas CA, Sevilla González MD, Tusie-Luna MT. Searching for the causal variants of the association between hypertriglyceridemia and the genome-wide association studies-derived signals? Take a look in the native American populations. Circ Cardiovasc Genet. 2017;10:pii:e002010.

20. Aguilar Salinas CA, Zamora M, Gómez-Díaz RA, et al. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis. Semin Vasc Med. 2004;4:203-9.

21. Huertas-Vázquez A, del Rincón J, Canizales-Quinteros S, et al. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families. Ann Human Genet. 2004; 68:419-27.

22. Suviolahti E, Lilja HE, Pajukanta P. Unraveling the complex genetics of familial combined hyperlipidemia. Ann Med. 2006; 38:337-51.

23. Weissglas-Volkov D, Plaisier C, Huertas-Vázquez A, et al. Identification of two common variants contributing to serum apolipoprotein B levels in Mexicans. Arterioscler Thromb Vasc Biol. 2009;30:353-9.

24. Vallejo-Vaz AJ, Kondapally Seshasai SR, Cole D, et al. Familial hypercholesterolaemia: a global call to arms. Atherosclerosis. 2015;243:257-9.

25. Robles-Osorio L, Huerta-Zepeda A, Ordóñez ML Canizales- Quinteros S, Díaz-Villaseñor A, Gutiérrez-Aguilar R, et al. Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico. Arch Med Res. 2006;37:102-8.

26. Vaca G, Vázquez A, Magaña M, Ramírez M, Dávalos I, Martínez E. Mutational analysis of the LDL receptor and APOB genes in Mexican individuals with autosomal dominant hypercholesterolemia. Atherosclerosis. 2011;218:391-6.

27. Mehta R, Zubirán R, Martagón A, et al. The panorama of familial hypercholesterolemia in Latin America: a systematic review. J Lipid Res. 2016;57:2115-29.

28. Santos R, Bourbon M, Alonso R, et al. Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries. J Clin Lipidol. 2017;11:160-6.

29. Vallejo-Vaz A, Akram A, Seshasai SK, et al. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS familial hypercholesterolaemia studies collaboration. Atheroscler Suppl. 2016;22:1-32.

30. Rivera-Hernández M, Galárraga O. Type of insurance and use of preventive health services among older adults in Mexico. J Aging Health. 2015;27: 62-982.